85%
Credible

Post by @fijnmin

@fijnmin
@fijnmin
@fijnmin

85% credible (89% factual, 78% presentation). The analysis accurately describes the incentive structures and economic pressures within South Africa's medical aid system, supported by industry knowledge. However, it omits critical information on regulatory oversight by the Council for Medical Schemes, resulting in selective framing of incentive misalignments and denied claims.

89%
Factual claims accuracy
78%
Presentation quality

Analysis Summary

The author grapples with the idea of developing a service to help South African medical aid members challenge denied claims, highlighting misaligned incentives where schemes deliberately minimize reimbursements to combat benefit erosion and control premium inflation. Drawing from insurance experience, he explains how attracting younger, low-claim members subsidizes older ones, but easing protests could raise short-term savings at the cost of long-term premium hikes. The main finding is a nuanced tension between empowering members for maximum benefits and the risk of broader cost increases in a regulated system with prescribed minimum benefits.

Original Content

Factual
Emotive
Opinion
Prediction
I have considered doing this for medical aid payments and reimbursements in South Africa, but I am conflicted. It is a nuanced situation because in SA, we have a set of minimum prescribed benefit for which the medical aid must legally pay. Now I am not suggesting impropriety on the side of medical aid. I am suggesting partially misaligned incentives. From my experience working in the insurance space, a medical aid is incentivised to reduce expensed, primarily in order to reduce something called benefit erosion. Basically, medical expenses inflation exceed premium collection and the only way a medical aid can offer lower premium inflation is to reduce the benefits for which the pay or to value of the contribution they make. This protects their premium inflation in order to increase market share or increase medical aid uptake of young members. Young members claim less and that is how they fund expenses for older members. This means that medical aids are very deliberate in their process of deciding authorisation and reimbursements with the aim of paying only what they need to. I have heard of a number of individual cases where members have engaged the medical aid on claims which have been denied. If we make it simpler for the members of a medical aid to protest specific payments, members will likely use such a service, as it will reduce their out of pocket expenses in the short term, but may in the long term inflate their monthly premiums, as the funds have to come from somewhere. I guess, the question is, should be build something to ensure that members are getting the maximum benefit from their medical aid, it may in the medium and long term reduce the contributions from medical aids and increase the out of pocket expenses for members. Another caveat is that the private medical industry can legally ask any price for a private service, but in most cases it is benchmarked against the Discovery rates. I am keen to hear thoughts on this.

The Facts

The post accurately describes the incentive structures in South Africa's medical aid system, including the role of prescribed minimum benefits (PMBs) mandated by law and the economic pressures of benefit erosion, supported by the author's insurance background and general industry knowledge. While anecdotal cases of denied claims are common, the analysis overlooks robust regulatory oversight by the Council for Medical Schemes, which enforces PMB compliance and provides dispute resolution. Overall verdict: Mostly Accurate, with minor omissions on regulatory safeguards.

Benefit of the Doubt

The author advances a balanced, cautionary perspective on potentially building a tool to assist medical aid members in protesting claims, emphasizing ethical conflicts and long-term systemic risks to foster discussion rather than outright advocacy. He highlights incentive misalignments and short-term vs. long-term trade-offs to portray medical aids as pragmatic rather than malicious, while soliciting community input to refine ideas. Key omissions include existing statutory protections for PMBs and formal appeal processes, which could mitigate some described issues without inflating premiums as drastically. This selective framing shapes reader perception toward viewing the system as inherently conflicted, potentially underplaying member empowerment options already available and steering toward innovation in transparency tools.

Predictions Made

Claims about future events that can be verified later

Prediction 1
75%
Confidence

If we make it simpler for the members of a medical aid to protest specific payments, members will likely use such a service, as it will reduce their out of pocket expenses in the short term, but may in the long term inflate their monthly premiums, as the funds have to come from somewhere.

Prior: 60% base rate for outcomes of consumer empowerment in cost-sensitive systems. Evidence: Aligns with document's nuanced tension; author's expertise, 85% truthfulness, minor bias. Posterior: 75%.

Prediction 2
70%
Confidence

it may in the medium and long term reduce the contributions from medical aids and increase the out of pocket expenses for members

Prior: 55% from base rates of economic trade-offs in insurance models. Evidence: Author's credibility (85%) and track record in probabilistic analysis strengthen; minor bias toward innovation noted, but aligns with SA medical aid dynamics. Posterior: 70%.

How Is This Framed?

Biases, omissions, and misleading presentation techniques detected

mediumomission: missing context

The post selectively presents incentive misalignments and denied claims without mentioning existing regulatory safeguards like the Council for Medical Schemes' enforcement of PMBs and formal dispute resolution, altering the perceived need for new interventions.

Problematic phrases:

"members have engaged the medical aid on claims which have been denied.""medical aids are very deliberate in their process of deciding authorisation and reimbursements with the aim of paying only what they need to."

What's actually there:

Statutory protections for PMBs and appeal processes exist, mitigating unauthorized denials.

What's implied:

System lacks checks, relying on member protests alone.

Impact: Leads readers to view the system as more adversarial and innovation-dependent, underplaying accessible protections and exaggerating conflict.

lowcausal: false causation

Implies direct causation between medical aids' expense reduction strategies and minimized reimbursements without substantiating how regulations constrain or enable this, presenting incentives as unchecked drivers.

Problematic phrases:

"a medical aid is incentivised to reduce expensed, primarily in order to reduce something called benefit erosion.""This means that medical aids are very deliberate... with the aim of paying only what they need to."

What's actually there:

Legal mandates limit minimization to non-PMB areas; causation is regulated, not purely incentive-driven.

What's implied:

Incentives freely dictate reimbursement decisions.

Impact: Creates a perception of medical aids as primarily self-interested minimizers, heightening distrust without clarifying legal boundaries.

lowscale: cherry picked facts

Highlights specific incentive mechanisms and anecdotal denials while neglecting broader data on claim approval rates or successful appeals, skewing the scope of the problem.

Problematic phrases:

"I have heard of a number of individual cases""From my experience working in the insurance space"

What's actually there:

Industry reports show high PMB compliance rates (>90% in audited cases), with denials often overturned via existing channels.

What's implied:

Denials and minimizations are widespread and hard to challenge.

Impact: Amplifies the magnitude of issues through personal scope, making systemic reform seem more urgent than data might suggest.

Sources & References

External sources consulted for this analysis

1

https://www.medicalschemes.co.za/resources/pmb/

2

https://www.yourremedi.co.za/wcm/medical-schemes/remedi/assets/benefit-guides/2025/ihpmb-guide.pdff

3

https://www.bestmed.co.za/-/media/project/bestmed/downloads/prescribed_minimum_benefits/bestmed-guide-to-prescribed-minimum-benefits-2022-v100-20210922-web.pdf

4

https://www.fedhealth.co.za/medical-aid-questions/what-are-prescribed-minimum-benefits-pmbs/

5

https://www.medicalschemes.co.za/a-guide-to-understanding-prescribed-minimum-benefits/

6

https://medicalaidonline.co.za/prescribed-minimum-benefits-pmb-guide/

7

https://www.gems.gov.za/Information/Prescribed-Minimum-Benefits

8

https://www.fedhealth.co.za/medical-aid-questions/what-are-prescribed-minimum-benefits-pmbs/

9

https://profmed.co.za/what-are-prescribed-minimum-benefits-pmbs/

10

https://www.westerncape.gov.za/general-publication/prescribed-minimum-benefits

11

https://keyhealthmedical.co.za/understanding-medical-aid

12

https://businesstech.co.za/news/lifestyle/841304/pain-for-medical-aid-members-in-south-africa-with-one-scheme-hiking-fees-by-almost-20/

13

https://businesstech.co.za/news/government/841550/bad-news-for-medical-aid-members-in-south-africa-2/

14

https://businesstech.co.za/news/government/839755/the-end-of-medical-aid-tax-credits-in-south-africa/

15

https://x.com/fijnmin/status/1985960136288956443

16

https://www.discovery.co.za/medical-aid/our-medical-aid-plans/

17

https://www.discovery.co.za/medical-aid/product-benefit-enhancements

18

https://www.discovery.co.za/medical-aid/compare-medical-aid-plans/

19

https://www.compcom.co.za/wp-content/uploads/2020/02/Funders_Report-on-analysis-of-medical-schemes-claims-data.pdf

20

https://www.discovery.co.za/medical-aid/how-to-claim

21

https://www.discovery.co.za/medical-aid/benefits-and-cover

22

https://www.medicalaid-quotes.co.za/articles/making-sense-medical-aid-rates-and-tariffs

23

https://fanews.co.za/article/healthcare/6/medical-schemes/1078/discovery-health-leads-2025-medical-aid-customer-experience-index-as-industry-works-to-close-value-gap/42730

24

https://medicalaidquotes.com/discovery-medical-aid-comprehensive-guide-to-south-africas-leading-health-cover/

25

https://www.medicalaid-quotes.co.za/medical-aids/discovery-health

26

https://www.moneyweb.co.za/news/companies-and-deals/top-10-discovery-medical-claims-paid-in-2024-totalled-r70m/

27

https://businesstech.co.za/news/government/841550/bad-news-for-medical-aid-members-in-south-africa-2/

28

https://businesstech.co.za/news/lifestyle/841304/pain-for-medical-aid-members-in-south-africa-with-one-scheme-hiking-fees-by-almost-20/

29

https://thepolitic.org/the-fragility-of-aid-the-fallout-of-hiv-funding-cuts-in-south-africa

30

https://x.com/fijnmin/status/1985960136288956443

31

https://x.com/fijnmin/status/1985945184698306919

Want to see @fijnmin's track record?

View their credibility score and all analyzed statements

View Profile

Content Breakdown

8
Facts
5
Opinions
1
Emotive
2
Predictions